Evidence map›Paper›PMID 23277562›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Smg1 haploinsufficiency predisposes to tumor formation and inflammation.

Tara L Roberts, Uda Ho, John Luff, C Soon Lee, Simon H Apte, Kelli P A MacDonald, Liza J Raggat, Allison R Pettit, Carl A Morrow, Michael J Waters and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Unraveling DNA Repair Processes In Vivo: Insights from Zebrafish Studies.International journal of molecular sciences · 2023
    Review
  12. The dual role of p63 in cancer.Frontiers in oncology · 2023
    Review
  13. Article
  14. Article
  15. DNA and RNA Binding Proteins: From Motifs to Roles in Cancer.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Tara L RobertsQueensland Institute of Medical Research, Brisbane, QLD 4029, Australia. tara.roberts@qimr.edu.au
Uda Ho
John Luff
C Soon Lee
Simon H Apte
Kelli P A MacDonald
Liza J Raggat
Allison R Pettit
Carl A Morrow
Michael J Waters
Phil Chen
Rick G Woods
Gethin P Thomas
Liam St Pierre
Camile S Farah
Raymond A Clarke
James A L Brown
Martin F Lavin
University of Queensland · AUQIMR Berghofer Medical Research Institute · AUIngham Institute · AUOllscoil na Gaillimhe – University of Galway · IEWestern Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SMG1 is a member of the phosphoinositide kinase-like kinase family of proteins that includes ATM, ATR, and DNA-PK, proteins with known roles in DNA damage and cellular stress responses. SMG1 has a well-characterized role in nonsense-mediated decay as well as suggested roles in the DNA damage response, resistance to oxidative stress, regulation of hypoxic responses, and apoptosis. To understand the roles of SMG1 further, we generated a Genetrap Smg1 mouse model. Smg1 homozygous KO mice were early embryonic lethal, but Smg1 heterozygous mice showed a predisposition to a range of cancers, particularly lung and hematopoietic malignancies, as well as development of chronic inflammation. These mice did not display deficiencies in known roles of SMG1, including nonsense-mediated decay. However, they showed elevated basal tissue and serum cytokine levels, indicating low-level inflammation before the development of tumors. Smg1 heterozygous mice also showed evidence of oxidative damage in tissues. These data suggest that the inflammation observed in Smg1 haploinsufficiency contributes to susceptibility to cancer and that Smg1-deficient animals represent a model of inflammation-enhanced cancer development.

Indexed as

AnimalsBase SequenceDisease Models, AnimalDNA, ComplementaryGenetic Predisposition to DiseaseHaploinsufficiencyHematologic NeoplasmsHomozygoteInflammationLung NeoplasmsMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMolecular Sequence DataNeoplasms, ExperimentalDNA, ComplementaryProtein Serine-Threonine KinasesSmg1 protein, mouse

Identifiers

PMID23277562
PMCPMC3557096
OpenAlexW2146459098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.